Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
about
Pharmacology and clinical experience with exemestane.The transdermal patches for site-specific delivery of letrozole: a new option for breast cancer therapy17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancerPlasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancerInfluence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.Aromatase inhibition 2013: clinical state of the art and questions that remain to be solvedAdvances in the adjuvant and neoadjuvant treatment of breast cancer.Additive endocrine therapy for advanced breast cancer - back to the future.Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.Aromatase inhibitors and other novel agents in breast cancer treatment.Aromatase inhibition for breast cancer treatment.Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
P2860
Q34075034-A3E80A66-6FC7-42E7-99BC-5C04889F2EB3Q34280259-7368101F-88AD-4588-BCD7-C82F6C68AE32Q34336534-7170C662-83B8-4A10-A8D3-BD0916E4BB6EQ35977200-477C8147-F8AE-4696-9C8B-86A0A65EC73FQ35979241-A3337110-25D0-4889-9950-AB97529435E2Q36079441-A1493FBC-5879-4DD6-9860-B6FFC9D55F53Q36138879-8CD1CF16-E66F-40A1-AFC5-81911FE9E032Q36946008-FCFB9BC1-105F-477B-97E2-4FD33E94267AQ37608406-B4882376-0AE1-4853-AB55-BD33136E2DDAQ37622884-823AF967-FA46-4FF2-90F9-50C0E4F45420Q39043672-55A601B4-5B3F-4ACB-A7B9-EB34A04FE1D2Q40409345-B4B6CB2E-8D27-40E2-954D-3CE321974B1BQ41463872-52138FE7-3528-414E-A3C5-29DBE5314A02Q51592342-E01F317E-779A-4B4B-B3C4-7D85D2A1D938
P2860
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@en
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@nl
type
label
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@en
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@nl
prefLabel
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@en
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@nl
P1476
Postmenopausal estrogen synthe ...... he treatment of breast cancer.
@en
P2093
P304
P356
10.1016/0022-4731(90)90241-J
P577
1990-03-01T00:00:00Z